Natera Inc (NTRA)
170.36
-0.04
(-0.02%)
USD |
NASDAQ |
Jan 08, 12:29
Natera Research and Development Expense (Annual): 320.68M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
Guardant Health Inc | 367.19M |
Progyny Inc | -- |
Delcath Systems Inc | 17.50M |
Star Equity Holdings Inc | -- |
CytoSorbents Corp | 15.73M |